Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Visionary Investigators Network – South Miami

Verified

Basic Information

Site Overview

Source: Human-provided.

Visionary Investigators Network (VIN) is a South Florida–based clinical research network specializing in neurology and pain management studies. The network operates through physician-integrated research sites in Aventura, South Miami, and Coconut Grove, enabling direct recruitment from established patient populations and supporting diverse participant enrollment. VIN conducts clinical trials across multiple therapeutic areas including Alzheimer’s disease, Parkinson’s disease, migraine and headache disorders, multiple sclerosis, epilepsy, diabetic neuropathy, CIDP, and myasthenia gravis. Led by board-certified neurologists and experienced clinical research professionals, the organization focuses on patient-centered research, high-quality data collection, and advancing innovative therapies through Phase II–IV clinical studies.

Source: Trial-derived.
1Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
0Active Trials
Source: Trial-derived.
1Completed Trials
Source: Trial-derived.
6Unique Conditions
Source: Trial-derived.
1Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Alzheimer Disease (1)Source: Trial-derived. Alzheimer Disease, Early Onset (1)Source: Trial-derived. Memory Disorders (1)Source: Trial-derived. Memory Impairment (1)Source: Trial-derived. Memory Loss (1)Source: Trial-derived. Mild Cognitive Impairment (1)

Sponsors

Source: Trial-derived. GAP Innovations, PBC (1)